"Funding?"

Chen Xiang's eyes were astonished. He believed that since the other party said such words, it proved that this was no small matter, and he would probably prepare for a big fight at some point in the future.

"According to Mr. He's capital scale, HSBC can provide a capital allocation limit of no more than 200 million Hong Kong dollars. As long as the decline does not exceed 11%, the forced liquidation mechanism will not be triggered."

Capital allocation is a routine operation in stock and securities trading, that is, a process in which customers use their own funds as guarantee and financial institutions provide a certain amount of funds to assist in transactions to achieve the purpose.

Of course, the interest on capital allocation is never low. After all, financial institutions also bear certain risks.

From the perspective of the investment department of HSBC, it provides capital allocation services to customers. It is also part of the financial services project. In many cases, investment operators will proactively provide capital allocation suggestions to customers.

"Two hundred million Hong Kong dollars? That's enough for the time being."

After thinking about it, He Zhou planned to use 5 million Hong Kong dollars of his own funds to buy Ximing Pharmaceuticals with 5 times the leverage. With 5 million in funds, he would leverage 25 million to buy Ximing Pharmaceuticals.

After confirming it, Chen Xiang did as he was told. Not long after, the investment department of HSBC Bank placed a short order of 25 million for Ximing Pharmaceutical.

It took about a quarter of an hour before the empty order was completely eaten up by other institutions.

Thanks to the 87% increase in Ximing Pharmaceutical's performance over the past year, Ximing Pharmaceutical's market value has directly increased by 118%, which is highly favored by the market.

Especially since Ximing Pharmaceutical released the news that it will "combine Chinese and Western medicine" and prepares to cooperate with mainland local governments in the cultivation and development of the traditional Chinese medicine industry in the mainland, it has become a favorite in the eyes of major institutions.

After completing this operation, He Zhou finally breathed a sigh of relief.

In a large room of the Kowloon Exchange, several employees who were following the news of Ximing Pharmaceutical in real time showed shock on their faces and quickly reported to their superiors.

"Boss, an empty order for Ximing Pharmaceutical just appeared. It's a 25 million order, and I took the final say and took one third of it."

"Twenty-five million empty orders?"

Hearing what his subordinates said, a middle-aged man dressed as a professional manager frowned and said with some surprise: "Where did this capital tycoon come from, and he actually came to play in a small pond like Ximing Pharmaceutical?"

After saying that, he almost subconsciously had a worried intuition, "There is no negative news about Ximing Pharmaceutical, right?"

"This...according to the news we have received, everything is business as usual, the fundamentals have not changed, and Ximing Pharmaceutical's stock price has been rising steadily."

Hearing this, the professional manager touched his chin and said, "That's weird. What's going on with this inexplicable empty order? Is it some wealthy guy who is willful? Or maybe Ximing Pharmaceutical has offended someone?" Could the stock price be sniped?"

At the end, he actually laughed first. Ximing Pharmaceutical is deeply involved with Australian capital and has abundant capital. Who has the strength to attack Ximing Pharmaceutical's stock price?

In all the big dyeing vats in Xiangjiang, those who have the ability to turn clouds over and rain rain with their backhand are only those at the top of the food chain.

As for British capital? British capital has always worn the same pants as Australian capital. Even if it is to maintain superficial unity, they will express an attitude of advancing and retreating together, rather than blatantly attacking Australian companies.

"Oh, by the way, this short order was posted through the HSBC Investment Department's seat." The subordinate added.

The professional manager's expression immediately relaxed, and he immediately smiled and said: "It seems that it may be hot money from Southeast Asia. They first set foot in Hong Kong and found HSBC. They want to be a dragon crossing the river for a time! I don't know if it will become a dragon in the end." A worm."

There was a lot of ridicule in his words, but to be on the safe side, he still called the boss of Ximing Pharmaceutical and informed him of the 25 million empty order.

As expected, with the backing of Australian capital and the secret support of the British Hong Kong government, the head of Ximing Pharmaceutical did not take this empty deal to heart. In fact, he was still thinking about whether to release some more benefits. The news will push up the stock price again, giving those who try to hide in secret short selling a taste of what it's like to lose money.

In the end, reason prevailed. Ximing Pharmaceutical has risen too sharply in the past year. If it continues to increase its stock price, it may damage Ximing Pharmaceutical's long-term future and cause more harm than good.

However, just as he put down the phone, another call came in urgently, almost startling him.

He slapped the pen on his desk angrily and yelled at his secretary angrily: "Who called again?!"

"Chairman, something bad has happened. News of a large number of Ximing Pharmaceutical's financial loopholes suddenly appeared on the market. It was cited by many media and even appeared on TVB's midday news..."

Snapped.

The sound of the phone falling was very clear, and then the man yelled directly into the phone: "Tell me clearly which bastard is spreading rumors, and you must find him out!"

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like